Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD. - Strassman AM; Melo-Carrillo A; Houle TT; Adams A; Brin MF; Burstein R (Cephalalgia : an international journal of headache, 2022)